GlassScriptPhysician profile
Rishelle D Greenlee
NPI 1255507125
$4,594.95
in general payments reported to CMS, 2019-2025
14 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $21.15 · 2022: $16.26 · 2023: $23.91 · 2024: $4,097 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $761 · Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $760.65 |
| Food and Beverage | $543.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,026.52 | 2024 | |
| Abbvie INC. | $202.96 | 2019-2025 | |
| Astellas Pharma US INC | $97.27 | 2025 | Veozah |
| Biogen, INC. | $53.42 | 2025 | Zurzuvae |
| Covidien LP | $36.09 | 2019 | |
| Hologic Sales and Service, LLC | $34.32 | 2024 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Allergan, INC. | $27.43 | 2019 | |
| Roche Diagnostics Corporation | $21.74 | 2019 | |
| Medtronic, INC. | $20.12 | 2024 | Truclear |
| Bard Access Systems, INC. | $17.10 | 2019 | |
| Scynexis, INC. | $16.26 | 2022 | |
| Coopersurgical, INC. | $16.08 | 2024 | Paragard T 380a |
| Millicent US INC | $13.49 | 2025 | Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rishelle Greenlee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.